findmyKOL
Clinical trialNCT03471260RecruitingPhase 1/PHASE2Interventional

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

SponsorM.D. Anderson Cancer CenterEnrollment96Acute Myeloid LeukemiaHematopoietic and Lymphoid System NeoplasmMyelodysplastic SyndromeMyeloproliferative NeoplasmRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Jacqueline S. Garcia, MD
    Recruiting
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

    Cleveland, Ohio, United States

    Hetty Carraway, MD
    Recruiting
  • Oregon Health and Science University

    Portland, Oregon, United States

    Curtis Lachowiez, MD
    Recruiting
  • M D Anderson Cancer Center

    Houston, Texas, United States

    Courtney DiNardo
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azacitidine →Ivosidenib →Venetoclax →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Mar 2018
Primary completion
30 Sept 2027
Completion
30 Sept 2027
Last update posted
11 Mar 2026
Registered enrollment
96
Registry id
NCT03471260
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.